Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study.

Lars Iversen,Curdin Conrad,Liv Eidsmo,Antonio Costanzo,Joanna Narbutt,Andreas Pinter,Külli Kingo,Raquel Rivera Diaz,Frank Kolbinger,ManikPrabhu Nanna, Jennifer Annika Frueh,Piotr Jagiello

Journal of the European Academy of Dermatology and Venereology : JEADV（2023）

引用 5|浏览9

暂无评分

摘要

Secukinumab was superior to nb-UVB in treating patients with new-onset moderate to severe plaque psoriasis. The high and sustained skin clearance observed indicates that biologic treatment for psoriasis may be more effective if used early in the disease course.

查看译文

关键词

severe plaque psoriasis patients,psoriasis patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要